(Q38093501)

28 August 2017

title

Coronary stents: historical development, current status and future directions (English)

1 reference

28 August 2017

3

Patrick W Serruys

1 reference

28 August 2017

Javaid Iqbal

1

1 reference

28 August 2017

Julian Gunn

series ordinal

2

1 reference

28 August 2017

publication date

26 March 2013

1 reference

28 August 2017

published in

British Medical Bulletin

1 reference

28 August 2017

volume

106

1 reference

28 August 2017

page(s)

193-211

1 reference

Coronary stents: current status

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

21 January 2018

Platelets and restenosis

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

In-stent stenosis: pathology and implications for the development of drug eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Incidence, predictors, and management of acute coronary occlusion after coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Angiographic follow-up after placement of a self-expanding coronary-artery stent

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Bare metal stent restenosis is not a benign clinical entity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Contribution of endogenous glucocorticoids and their intravascular metabolism by 11β-HSDs to postangioplasty neointimal proliferation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

21 January 2018

Estrogen-eluting stents

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Rapamycin inhibits vascular smooth muscle cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Sirolimus-eluting coronary stents: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

An overview of the TAXUS Express, paclitaxel-eluting stent clinical trial program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8, 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

The influence of physical stent parameters upon restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Comparison of zotarolimus-eluting and everolimus-eluting coronary stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Stent development and local drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Eve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Safety and efficacy of everolimus- versus sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Effectiveness and safety of drug-eluting stents in Ontario.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Strategies for multivessel revascularization in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Guidelines on myocardial revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Bifurcation stenting: current strategies and new devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

21 January 2018

New P2Y₁₂ inhibitors.

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Intracoronary optical coherence tomography: a comprehensive review clinical and research applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Coronary stents: looking forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Biodegradable coating for drug-eluting stents--more than a facelift?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Biodegradable metals for cardiovascular stent application: interests and new opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Long-Term (>10 Years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki-Tamai stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

Novel use of a pericardium-covered stent graft to treat bulky coronary artery thrombus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDT009

21 January 2018

Identifiers

DOI

10.1093/BMB/LDT009

1 reference

28 August 2017

1 reference